Portfolio

13books Capital invests in tomorrow’s financial technology. Founded with a mission to back bold founders creating the world-changing financial technology of tomorrow, 13books Capital has invested in Europe's best fintech founders. Coupled with the experience and knowledge of its network, 13books Capital backs the journey of founders to realise their ambitions to scale globally.

3VC is a Vienna-based VC fund that invests in a carefully hand­picked group of European technology startups with global ambition. Focusing on Series A and above, 3VC’s team supports founders from DACH and CEE region. 3VC’s portfolio includes companies like Avi Medical, Kaia Health, PactumAI, Lokalise, Storyblok.

Founded by industry veterans, 415 Capital is a Munich-based VC firm which invests in innovative MedTech startups in Europe, Israel, and the United States. In over 25 years, the founding partners have funded more than 50 startups and introduced dozens of novel therapies to market.

42CAP investors Alex Meyer and Thomas Wilke invest very early in young companies with global ambitions. The 42CAP credo of peers reflects their investment approach, supporting data- and technology-based business models, product-driven founders, and sustainable business development.

Acton Capital Partners is a leading European venture capital fund head­quartered in Munich. The Acton team has been successfully investing growth capital in Internet companies since 1999.

AENU is an Article 9 climate tech VC fund focused on early-staged companies in northern Europe. Its diverse team includes former unicorn founders, climate activists, and institutional investors. Specializing in the energy transition and carbon economy, AENU's portfolio has achieved several, with recent investments in Monta, alcemy, Agreena, Undo, and Ocell.

Ananda Impact Ventures is the leading impact venture capital fund with a pan-European investment mandate and is backed by renowned institutional and private investors. Ananda manages around EUR 200m in 4 impact funds and finances technology companies that address social and environ­mental challenges in a scalable and sustainable way.

Andera Partners is a leading investor in minority investments into privately owned companies with more than €2 billion under management. Its Life Sciences team of 11 professionals brings together deep experience both in the Life Science industry and in private equity and venture capital.

APEX Ventures is a European venture capital firm focusing on early-stage deep-tech companies with the potential to become global market leaders. Headquartered in Austria and operating across Europe, APEX works with ambitious founders who are developing transformative technologies in sectors where Europe has strong research expertise, technical talent and industrial depth.

Apollo Health Ventures is a trans­atlantic venture capital firm investing in data-driven biotechnology and health tech ventures within the aging sector. Apollo invests in the early stages of a venture and actively builds its portfolio companies.

Armira Growth provides EUR 10 - 15M of growth capital to European tech entrepreneurs in fast-growing companies with proven business models.

Astanor Ventures - where tech meets nature - is an impact investor that backs disruptive entre­preneurs in Europe and beyond with ambitious, scalable plans to create systemic change in the food production and agriculture supply chains, aiming to restore balance and sustainability to our environment and oceans.

Atlantic Labs is a leading European pre-seed fund, headquartered in Berlin. Founded by Christophe F. Maire, Atlantic Labs has acted as lead-investor in 100+ early-stage companies since 2013. Building on its team of experienced venture developers and industry network, Atlantic Labs helps companies succeed and find strong inter­national follow-on investors.

BGV is focused on early-stage European biotech companies. The life science VC firm has a strong track record through investing in healthcare innovations and providing the expertise to build world-class teams. Since its inception BGV raised over €220 million across four funds. BGV is based in Naarden, The Netherlands, and collaborates with Forbion.

Biomed is a leading early-stage VC at the center of European biotech. We build companies around the most intriguing innovations. We strive to enable founders and their ideas. We focus on scientific excellence, building companies to create medical and commercial value and develop new medicines that improve patient’s lives.

BlackFin is focusing on European FinTech and InsurTech oppor­tunities, leveraging its unique sector expertise to help the best entre­preneurs achieve outstanding growth.

Bootstrap Europe is a technology debt fund which provides progressive, ambitious entrepreneurs and their shareholders with non-dilutive funding to help them embark on the next chapter of their growth journey. Having invested over EUR1bn in growth loans, the Bootstrap team supports thriving industries across the globe, from quantum computing, semiconductors, green energy and genetic testing to SaaS, fintech and life sciences.

Capnamic Ventures, which is based in Cologne and Berlin, is one of Europe’s leading early-stage venture capital investors. Its investments are focused on technology start-ups in German-speaking countries. Capnamic brings together institutional and corporate investors, offering its portfolio companies a unique network of sparring partners and customers.

Cavalry is a Berlin-based early-stage fund that actively supports European startups with entre­preneurial know-how and financing. The firm builds upon a strategically curated LP network and supports its portfolio companies in all mission critical areas such as go to market or product.

Cherry Ventures is an early-stage venture capital fund based in Berlin which was founded in 2012 by a team of start-up entrepreneurs. It invests in seed and series A phases from a EUR 150 million fund and specialises in companies with a focus on technology in the software industry. Current investments include Flixbus, Auto1, Tourradar, AMBOSS and Quandoo.

Founded in 2003, Cipio Partners is a leading investment management and advisory firm for European growth capital & minority buyouts for technology companies, with offices in Munich and Luxembourg. Cipio Partners targets European growth stage technology businesses with €10-50m in revenue and makes initial investments ranging from €5-15m.

Claret Capital Partners provides growth capital to innovative growth stage businesses. The Claret team have been active in the technology financing markets for over 20 years and provide innovative debt solutions to help entre­preneurs and private equity investors grow their companies while minimising dilution.

Contrarian Ventures is the early-stage VC for climate generation, mobilising resources for climate action in Europe & Israel with collaborative, hands-on, founders-first approach. Benefitting from unparalleled levels of engagement with the climate tech community, their platform-based model backs the pioneers building the technology that will become the infrastructure of tomorrow. Given that decades of collective actions got Contrarian Ventures into the climate mess, they leverage Energy Tech Summit, Energy Tech Challengers, Climate Brick, Growth Meets Capital and Climate50 to make a collaborative effort to mobilise resources and get humanity back on track to decarbonize the economy.

coparion is a venture capital investor for young innovative Startups. Operating a fund with EUR 225 million under management, coparion accelerates momentum and contributes to sustainable growth. coparion provides financing together with co-investors EUR 0.5 to 5 million per financing round and up to EUR 10 million per company.

Cusp Capital is a German Venture Capital fund specialized in investments in Consumer Internet, Digital Services, and Emerging Technologies. The team’s focus is on investments in early growth stages (Series A, B) in Germany and Continental Europe.

Earlybird focuses on European tech companies. Founded in 1997, we invest in growth and development phases, supporting portfolio companies with financial resources, strategic support, access to inter­national networks and capital markets. We invest out of a family of focused + independently-managed funds: Digital West, Digital East, Healthcare, UNI-X & Growth Opps.

eCAPITAL is one of Germany's leading technology venture capital firms with more than EUR 400 million in AUM. The fifth fund generation eCAPITAL V is the largest eCAPITAL fund to date with EUR 160 million. The fund is investing in deeptech, sustainability tech, software and cybersecurity.

Emerge is the first cheque for founders defining the future of work and learning. A global pre-seed fund backed by more than 100 of the world’s best future of work and learning operators. Their vision is to democratise access to opportunity by being a catalytic partner for early-stage founders and providing access to a community who have ‘been there and built it’ with unrivalled market-specific know-how.

EMH Partners is an investment company of entre­preneurs for entre­preneurs based in Munich. The next-generation private equity firm bridges the gap between venture capital and buyout funds by providing capital and digitization expertise to mid-sized companies.

Since 2006 Endeit invests in European tech scale-ups across 7 countries. With offices in Germany, The Netherlands and Sweden, we support entre­preneurs during the growth stage to build global category leaders. We follow our thesis of Intelligent Empowerment and focus on tech companies that are driven by AI, deep learning, and demo­cratized algorithms.

ETF Partners supports talented entre­preneurs and management teams with investment capital and experience. Our funds come from institutional investors, global corporations, and family offices. We create value by investing in technology companies that make a difference. We call it ‘sustainability through Innovation’.

Extantia Capital is a climate-first venture capital firm accelerating the path to a decarbonised world. Extantia unites mission-driven entre­preneurs, scientists, investors, and business leaders to advance the transition. The platform includes Extantia Flagship, a fund backing scalable deep decarbo­nisation companies, Extantia Allstars, a fund-of-funds investing in climate venture capital funds, and Extantia Ignite, a sustainability hub advancing knowledge and competence in climate innovation and ESG practices.

Felix Capital is a London-based VC firm, managing over $1.4B of Venture and Growth capital, investing principally in Europe and selectively in North America. Felix invests thematically, at the intersection of technology and creativity, with a vision to empower new ways of living and working. Felix Capital was founded in 2015 by Frederic Court, who has worked in the technology industry for over 25 years, previously as a General Partner with Advent Venture Partners in London, and prior to that as an entrepreneur.

Fly Ventures is a Berlin-based VC firm investing in seed stage companies across Europe. Fly focuses on Enterprise and Deep Tech startups with initial ticket sizes of €500k to €1.3M.

FoodLabs is a pan-European early-stage VC investor and venture studio for food, sustainability and health. We strongly believe that entre­preneurship holds the key to pushing the boundaries in the food industry. Based in Berlin and founded by Christophe F. Maire, FoodLabs has built and invested in more than 40 early-stage FoodTech companies since 2016.

Forbion is a leading venture capital firm that works closely with entre­preneurs to build life sciences companies that transform people’s lives. Forbion’s portfolio companies are developing novel drugs, medical devices, and diagnostics for high and unmet medical needs.

Gilde Healthcare is a specialized healthcare investor managing over €1.4 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare is head­quartered in Utrecht (NL) and has local offices in Frankfurt (G) and Cambridge (US).

The Green Generation Fund invests in disruptive technologies at seed stages to enable break­throughs in Food Tech and Green Tech. We support passionate, mission-driven founders who build game changing companies within the realm of environ­mental sustainability, the single most urgent goal of humankind.

Hadean Ventures is a European life science VC fund manager with ca. EUR 250m assets under management. Hadean invests across all health­care verticals and stages in products with the potential to address unmet medical needs, making a difference by supporting the future of healthcare.

Founded in 1998, Headline is a global VC fund with an investment focus on early and growth-stage consumer internet & software companies. The firm invests out of dedicated funds in the US, Europe, Asia & South America. Headlines' portfolio comprises various category creators such as Acorns, AppAnnie, Blinkist, Farfetch, NGINX, Segment, and Sonos.

The seed investor High-Tech Gründerfonds (HTGF) finances technology start-ups with growth potential. With a volume of EUR 316.5 million in the third round of funding along with an inter­national partner network, HTGF has supported 500 start-ups since 2005. The team of experienced investment managers use their expertise to support young businesses.

HPE Growth Capital (founded in 2010, total committed capital of c. EUR 400 million) invests in and supports technology companies in Northern Europe with emphasis on Germany and the Benelux. Our vision is to accelerate growth of tomorrow's market leaders.

Since 2000, HV Capital has backed Internet and technology companies through various generations of funds and is one of the most successful and financially strongest early-stage and growth venture capitalist in Europe. HV’s funds have already invested in around 200 companies, including Zalando, Delivery Hero, FlixMobility, and SumUp.

Innovation Industries is a leading European deep-tech VC firm that invests in startups and scale-ups with a positive impact on the United Nations Sustainable Development Goals. The fund typically invests €10 to 40 million per company, across multiple funding rounds.

IRIS is a European venture and growth firm specialising in technology, investing in seed, Series A, late stage and growth. With offices in Paris, Berlin and Munich and deep market expertise, IRIS partners with scale-ups and technology leaders to increase their visibility, expand their business reach and create lasting global impact through its robust international network.

Join Capital is a Berlin-based, early-stage VC firm investing in the European Neue Industry. With a combined experience of more than 50 years among the partners, Join focuses primarily on industrial and enter­prise startups that are laying new foundations for our increasingly automated and connected world. Join’s extensive network and expertise make it a unique VC for the European industrial landscape.

Keen Venture Partners is a radically human venture capital firm based in Amsterdam and London. It backs exceptional teams and fast-growing scaleups across Europe. Keen aims to begin relationships by investing time first, money later by sharing its network, experience, and capabilities well before any investment possibility arises.

Korelya Capital is a pan-European venture capital firm investing in tech startups with global ambition. With presence in Paris, London, Singapore, and Seoul, Korelya Capital supports its portfolio companies in their growth in Europe and Asia.

As the pioneer growth debt provider across the UK, Europe, Scandinavia, and Israel, Kreos has a proven track record of adding value to portfolio companies and helping them grow with additional capital and flexibility throughout their business cycle. Kreos co-operates closely with both the portfolio company management team and their equity sponsors.

La Famiglia is a venture capital fund, backing strong early and growth stage technology startups that enable or disrupt established industries. La Famiglia has built a unique family of thought leaders around the fund, creating lasting connections within a tight-knit circle of founders, investors, and new and old economy industry leaders.

Lauxera Capital Partners is an independent, international healthcare-focused asset management firm based in Paris and San Francisco. Our growth equity investments focus primarily on commercial-stage healthcare companies. Led by entrepreneurial company builders and experienced healthcare investors, we enable European healthcare entrepreneurs to realise the growth promised by their innovations.

LSP is Europe's largest and most experienced health­care investment firm with offices in Amsterdam, Munich and Boston. With a track record going back more than 30 years, we have built an investment house that is dedicated to seeking, nurturing and growing health­care investment opportunities.

Marondo Capital was founded by four industry veterans with the objective to accompany the next generation “Mittelstands” companies in Germany to transform into market leaders in their industry segments. The fund focuses on growth and invests in businesses in the classical German Engineering verticals, including Industry 4.0.

Nauta Capital is a pan-European Venture Capital firm investing in early-stage technology companies, with offices in London, Barcelona, and Munich. With over half a billion assets under management and a team of 24 people, Nauta Capital is one of Europe’s largest B2B focused VCs.

Nextech is a cancer therapeutics-focused venture capital firm headquartered in Zurich, with affiliate offices in Boston and San Francisco. The investment program is founded on scientific expertise, an active group of Science Partners, and deep domain experience. This expertise allows Nextech to identify and evaluate potential investments, validate science, and build strong syndicates. As an active investor Nextech is working closely with management teams to shape some of the best new biotech companies.

NAP is Europe’s first GreenTech Growth Fund (SFDR Article 9), established in 2017, with offices in Copenhagen and Munich (400mEUR AUM). The fund's strategy is to spot and rapidly scale technology pioneers that can accelerate the global green transition, via a highly operational ownership model and a self-developed value creation toolkit, optimized for capital-efficient growth scaling.

Munich-based Nordwind Growth invests growth capital in young, founder-led tech companies in the DACH region with revenues of € 3 million or more. Since 2012, Nordwind Growth has been supporting tech companies in scaling and internationalizing their business models with its investments and its operationally experienced team.

Norrsken VC is Europe's leading early-stage fund investing in impact. Head­quartered in Stockholm with an investment philosophy framed around the UN's 17 SDGs, Norrsken VC backs startups solving the world's biggest problems while building massive businesses. The 40+ portfolio companies include three "impact unicorns" – Einride, Northvolt and 1KOMMA5°.

Founded in 2009 and head­quartered in London, Notion Capital is Europe's leading early-stage investor in Business Software and Fintech companies. The firm's founding team has worked together for over 25 years as entrepreneurs, operators, and investors, bringing a combined total of 50 years' investing experience underpinned by 100 years' experience as operators. Now, with a team of more than 30 individuals, including a dedicated 7-person Platform Team focused exclusively on adding value across the portfolio, Notion has completed more than 100 investments in European Business Software and Fintech, across five early-stage, and two growth capital funds.

Nucleus Capital is a sector-focused climate deep-tech VC providing industry specific support and first checks to entrepreneurs solving systemic challenges to planetary health.

Oxx partners with the most promising European B2B software companies at the scale-up stage. Oxx provides each entre­preneur with a support system of unique specialist expertise and network, and a culture of unfaltering partnership and absolute conviction. The firm’s strategy is built around the concept of “Go-To-Market Fit”, developing a structure for thinking about how to build a repeatable, sustainable growth engine that accelerates and propels the growth of SaaS companies.

Oyster Bay Venture Capital invests in impact driven founders across the food value chain in Europe. Oyster Bay invests primarily as lead investor in seed and series A rounds. The firm was founded in 2018 by Christoph Miller and is based in Hamburg, Germany.

Based in the UK and the US, Pact VC is a venture capital firm, investing in early-stage global disruptors solving pressing challenges. They support companies that democratize access, enhance well-being, and develop sustainable solutions for climate change. With over 40 years of experience as tech operators and investors, the team provides capital, strategic guidance and operational expertise to create lasting impact.

Partech is a global investment platform for tech and digital companies investing at the seed, venture, and growth stages. Partech is led by ex-entrepreneurs and operators of the industry and is spread across offices in San Francisco, Paris, Berlin, and Dakar.

Planet A Ventures invests in European green-tech startups with the goal of contributing to an economy within the planetary boundaries. As the first European VC, Planet A uses scientific life cycle assessments to identify companies that have a significant positive impact on our planet.

Project A is the operational VC based in Berlin. Since 2012 Project A invests in passionate early-stage entrepreneur. All portfolio companies are provided with exclusive access to 100 operational experts. The portfolio includes i.a. Kry, Sennder, Voi, Spryker.

Founded in 2006, redalpine is a leading European venture capital fund that empowers GameChangers. With over €1bn in AuM, the firm has backed some of Europe’s most disruptive software and science companies, including N26, Taxfix, Mistral, Aktiia, and Infinite Roots. redalpine has over 100 companies in its portfolio and offices in Zurich, Berlin, London, and a presence in San Francisco.

Samaipata is an early-stage founders’ fund investing in digital platforms displaying increasing returns at scale, across Europe. The fund was created by José del Barrio, co-founder of La Nevera Roja, sold for $100 million to Rocket Internet and Eduardo Díez-Hochleitner, current Chairman at MásMóvil.

"Building European Healthcare Champions" is the guiding principle of the Tübingen-based sector investor SHS. With this in mind, the investor specializing in health­care investments finances and develops its portfolio companies. Since its foundation in 1993, the focus of its investments has been on expansion financing, shareholder changes and succession situations.

Singular is a European venture firm partnering with remarkable founders building transformative companies. They take a highly collaborative approach and are committed to bringing tangible value, from the earliest moments through all stages of their growth. Singular helps the most innovative entrepreneurs fulfil their potential, working side by side to create the conditions for global success.

Sofinnova Partners is a leading European VC firm specialized in Life Sciences with head­quarters in Paris and offices in London and Milan. With over €2 billion under management, the firm brings together a team of 40 professionals from all over Europe, the U.S. and Asia and invests from very early-stage opportunities to late-stage/public companies.

Speedinvest is a leading early-stage venture capital firm with more than €1B AuM and 40+ investors based in Berlin, London, Munich, Paris, and Vienna. Wefox, Bitpanda, TIER Mobility, GoStudent, Wayflyer, Open, CoachHub, Schüttflix, TourRadar, Adverity, and TWAICE are among our portfolio of 250+ companies.

TVM Capital Life Science is a trans­atlantic venture capital firm based in Munich and Montreal and a demon­strated success of being more than 35 years in the business. Our exits include about 100 initial public offerings on NASDAQ and various European Exchanges as well as multiple trade sales and mergers.

Unternehmertum Venture Capital Partners (UVC Partners) is an early-stage venture capital firm investing in technology-based start-ups in Europe, primarily in German-speaking regions. UVC Partners is focused on companies in the areas of Industrial Technologies, Enterprise Software and SaaS, and Mobility.

With offices in Paris, Munich, and Helsinki, Ventech supports tech entre­preneurs in Europe as a close partner from series A onwards. We keep a clear focus on ground­breaking innovation fostering the digi­talization of our economy.

Visionaries Club is a Berlin-based early stage VC fund focused on B2B. It’s backed by leading European digital founders and family business entre­preneurs bridging information asymmetries between the old and new.

Vsquared Ventures backs bold entre­preneurs engineering seemingly impossible solutions to the world’s most pressing challenges. Investing in deep tech companies, Vsquared Ventures focuses on quantum and novel computing, green energy, robotics, AI/ML, tech-bio and new space technologies. Vsquared Ventures has built one of Europe’s strongest deep tech portfolios, including industry disruptors Isar Aerospace, IQM Quantum Computing, Zama.ai, Customcells, Neura Robotics, and The Exploration Company.

Wellington Partners is one of Europe's leading VC companies. With life science funds of more than EUR 400 million, Wellington Partners has been financing the develop­ment of innovative medical products since 1998, with the aim of generating highly attractive returns, and actively supports companies in developing successful business models.

World Fund is the leading Europe-focused climate venture capital fund established by Daria Saharova, Danijel Višević, Craig Douglas, and Tim Schumacher. From energy, food, agriculture, and land use, to building materials, manu­facturing and transport, World Fund is investing in European tech with significant climate performance potential (CPP). The investment team comprises engineers, physicists, chemists, biologists, early and growth stage investors. World Fund is backing those entre­preneurs who are building tech for a regenerative world.

Yttrium, based in Frankfurt, Munich, and London, provides growth equity for B2B technology companies across Europe and with a focus on DACH.

YZR Capital is a Pan-European venture capital fund focused on early-stage pioneering health­care technologies. YZR has a long-term investment focus, leveraging the value of a synergistic investment team with a professional investor culture, entrepreneurial experience and deep industry expertise.

ZINTINUS is a Food Tech venture capital fund focused on growth opportunities in Europe and the US. It aims to make a positive contribution to the transition of the Food System. ZINTINUNS is determined to support the upcoming wave of food system innovations, accelerate them and contribute to their success.